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INTRODUCTION: 
The prevalence of the diabetes is increasing particularly in  
developing countries. Estimate of global d iabetes 
prevalence predict 6.4%, affecting 285 million adults in 
2010, and will increase to 7.7% and 439 million adults by 
2030. India has largest number of diabetic patients in the 
world. The International Diabetes Federation (IDF) 
reported that the total number of d iabetic subjects in India 
is 41 million in 2006 and that this would rise to 70 million 
by the year 2025. Increased prevalence in India is 
attributed to the lifestyle transition coupled with 
urbanization, industrializat ion and lifestyle changes .
1
  
Diabetes is a chronic illness that requires continuous 
medical care and patient education in order to prevent 
microvascular and macrovascular complicat ions.  The risk 
of heart disease and stroke is two to four fo lds greater 
among people with diabetes.
2
  The complications of 
diabetes is to a large extent the consequence of 
macrovascular (coronary artery disease, peripheral 
vascular disease, and atherosclerosis) and microvascular 
(like retinopathy, neuropathy, and nephropathy) 
complications of the disease.
3,4
 
Diabetes care aims at improv ing the quality of life of 
diabetic patients through good glycemic control, control of 
risk factors, lifestyle modification, prevention of 
complications and diabetes education. Diabetes education 
is the cornerstone of diabetes care.
5
 Diabetes knowledge 
may enhance the ability of diabetic patients to cope and 
adjust to their illness. Similarly, patients with greater 
understanding and knowledge of their medications have 
been shown to have better glycaemic control. On the other 
hand, poor knowledge of diabetes is associated with 
increased rate of hospitalizat ion for unstable diabetes. 
Patients need to make informed  decisions about diet, 
exercise, weight control, blood glucose monitoring, 
medication usage, foot and eye care, and control of 
macrovascular risk factors.
6
  
Patient counseling is defined as providing medicat ion 
related information orally or in written form to the patient 
or their representatives, on topics like direction of use, 
advice on side effects, precautions, storage, diet and life 
style modification.
7
 Patient’s knowledge of medication use 
is of vital importance in the treatment success. The clear 
understanding of diagnostic and treatment advice 
correlates with adherence, which in turn leads to 
achievement of health.
8
 One study showed that intensive 
diabetes education and care management can improve the 
patient outcomes, glycemic control and quality of life in  
patients with diabetes mellitus.
9
 The reasons for patients 
not achieving treatment goals may include underutilizat ion 
of medications, poor medication adherence, under 
appreciation of goal attainment importance, or lack of goal 
knowledge.
10
  
The role of pharmacists has changed dramatically over the 
past 30 years. Traditionally, pharmacists have been viewed 
as individuals who dispense medications to the public. The 
concept of pharmacy practice has gradually changed from 
a product oriented activity to a patient-oriented one. 
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Pharmacists are now becoming indispensable in 
monitoring drug therapy in institutional settings.
11 
The goals of the Diabetic Education Program are to 
provide the highest quality education, medical care, and 
ongoing cultural and emotional support for all diabetics.
12
 
Diabetes education has been an essential component of 
diabetes management since the 1930s and is increasingly 
recognized as an integral part of chronic disease 
management.
13
 India is currently lacking structured 
education and information programme regarding diabetes. 
Obtaining information on level of awareness about 
diabetes is the first step in formulating a prevention 
programme. But a less attempts are done to assess the 
educational need of the patients and studies are mos tly 
from urban area. The lower awareness must be present in 
rural area, very few of them are d iagnosed and on regular 
treatment.
14
 
So in present study we had assessed the existing 
knowledge of diabetic patient and further evaluated the 
effectiveness of patient education about diet, lifestyle 
modification, disease, medication and medicat ion 
adherence, on clinical outcome in hospitalized diabetic 
patients. The objective of study includes: 1. To evaluate 
the effectiveness of patient education on clinical outcome 
of hospitalized diabetic patients. 2. To assess the baseline 
knowledge of the patient towards diet, lifestyle 
modification, disease, medication and medicat ion 
adherence. 
METHODOLOGY:  
Study Site: 
The study was carried out at Department of Medicine, 
H.K.E.S’s Basaveshwar Teaching and General Hospital, 
Gulbarga, Karnataka, India. 
Study design:  
A hospital based prospective study. 
Study duration: 
The study was carried out for a period of 6 months, from 
May 2010 to October 2010. 
Study criteria: 
The Diabetic patients visiting In patients Department of 
Medicine were enrolled in to the study after obtaining their 
verbal consent and by considering following inclusion and 
exclusion criteria. 
Inclusion criteria: 
 Patients with age of above 18 years and of either sex.  
 Patients having HbA1C above 7.5% 
 Patients diagnosed with Diabetes Mellitus and on 
treatment at least since last 1 year. 
Exclusion criteria: 
 Patients newly diagnosed with Diabetes Mellitus . 
 Patients not willing to participate in the study.  
 Patients with pregnancy and lactating women.  
Source of data: 
 Case Sheets and treatment charts of Inpatients.     
 Laboratory reports of the Patients . 
Study procedure:  
Those patients, who met the inclusion criteria, were 
enrolled at the time of discharge into the study after 
obtaining their verbal consent.  Patient demographics like 
age, family history, dietary habits, past and present 
medical and medication history were co llected.  
Patient Education and Follow up: The baseline patient 
knowledge regarding diet, lifestyle modification, disease, 
medication and medicat ion adherence were assessed. 
Based on patient’s  baseline knowledge and educational 
profile the patients educated and also provided informat ion 
leaflet covering all essential points . The baseline glycemic 
lab parameters glycosylated hemoglobin (HbA1c), fasting 
blood glucose (FBS), postprandial blood glucose(PPBS), 
blood pressure (BP),  were obtained from laboratory 
reports.  
The patients were asked to come back for follow-up once 
in 45 days, for a period of 3 months. During 1
st
 follow-up, 
FBS, PPBS and BP of the patients was noted. During 2
nd
 
follow-up, HbA1c, FBS, PPBS and BP of the patients was 
noted. The data collected was statistically analyzed by Chi-
square test and column statistic. 
RES ULTS: 
Table 1: Demographic details of the Patient  
S.N. Particulars No. of Patients 
(n=121) 
01 Gender 
Male 
Female 
 
86 (71.1%) 
35 (28.9%) 
02 Age (in years) 
21-40 
41-60 
61-80 
 ˃80 
 
07 (5.8%) 
56 (46.3%) 
54 (44.6%) 
04 (3.3%) 
03 Education 
Illiterate 
School 
Pre-University 
University 
 
53 (43.8%) 
46 (38%) 
12 (9.9%) 
10 (8.26%) 
04 Duration of DM (in years) 
1-5 
6-10 
11-15 
 ˃16 
 
39 (32.2%) 
44 (36.4%) 
26 (21.5%) 
12 (9.9%) 
05 Family History 
Yes  
No 
 
41 (33.9%) 
80 (66.1%) 
06 Diet 
Veg 
Non-Veg 
Mixed 
 
33 (27.3%) 
23 (19 %) 
65 (53.7%) 
07 Complications 
Retinopathy 
Neuropathy 
Cardiovascular  
Cerebrovascular  
Cardio + Cerebrovascular  
Renal + Cardiovascular  
 
02 (1.65%) 
02 (1.65%) 
64 (52.9%) 
06 (4.95%) 
08 (6.6%) 
10 (8.3%) 
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A total of 134 Diabetes Mellitus II patients were enrolled 
into the study, out of which, 121 patients have completed 
the study and remaining 13 patients did not turn up for the 
follow up. The data of only those patients who completed 
the study were analyzed. The demographic details of the 
enrolled patients shown in table 1.  
The prescription detail of the patients shows that, 37.2% of 
the patient s on combination of Insulin and OAD’s. The 
prescription details of the patients shown in table 2. 
The patient’s baseline knowledge was assessed towards 
diet, lifestyle modificat ion, disease, medication and 
medication adherence. The details of the baseline 
knowledge shown in table 3.  
Table 2: Prescript ion details of the patient: 
S.N. Therapy No. of Patients  
(n=121) 
01 Oral Antidiabetic Therapy 
(OAD’s) 
Monotherapy 
Two-drug Therapy 
Three- Drug Therapy 
 
32 (26.4%) 
65 (53.7%) 
24 (19.8%) 
02 Insulin Therapy  + OAD’s 45 (37.2%) 
 
Table 3: Details of the baseline knowledge of the patient 
S.N. Knowledge assessment questionnaires No. patients answered 
correctly (Percentage) 
01 Diet: 
1. Do you know the effect of food on blood glucose? 
2. Do you know the food with highest carbohydrate content? 
3. Do you know the food with highest fat content? 
4. Are you following a controlled and planned diet? 
5. Do you have an idea about the well-balanced diet?  
 
62 (51.2%)  
39 (32.2%) 
60 (49.6%) 
57 (47.1%) 
35 (28.9%) 
02 Lifestyle Modification 
6. Do u Know lifestyle modifications, including smoking cessation, weight control, and exerc ise is 
essential to control blood glucose.  
 
71 (58.7%) 
 
03 Disease: 
7. Do you know what Diabetes Mellitus is? 
8. Do you know the type (type I or Type II) of diabetes you are suffering?  
9. Do you know the major cause of diabetes? 
10. Do you know the complications of diabetes, if it’s not treated or not well controlled?  
11. Do you know how to manage hypoglycemic symptoms? 
 
47 (38.8%) 
92 (76%) 
64 (52.9%) 
40 (33%) 
72 (59.5%) 
04 Medication Knowledge: 
12. Do you know the name of the drug? 
13. Do you know how to take medicines? 
14. Do you know when to take medicine? 
15. Do you know side effects of the drugs? 
16. Do you know how to store the drugs? 
 
31 (25.6%) 
102 (84.3%) 
91 (75.2%) 
24 (19.8%) 
78 (64.5%) 
05 Medication Adherence  
17. Do you ever forget to take medicines?                                                 
18. Are you careless about timing of your medicine?                                            
19. When you feel better, do you sometimes stop taking your medicine? 
20. Sometimes if you feel worse when you take your medicine, do you stop taking it?       
21. When you travel or leave home, do you sometimes forget to carry your medication?                                                                                                  
 
68 (56.2%) 
45 (37.2%) 
76 (62.8%) 
43 (35.5%) 
62 (51.2%)
 
Assessment of patient’s FPG level from baseline to first 
follow up showed a mean increase in 183.5±31.54 and P < 
0.05 which is statistically significant.  The patient’s PPG 
level from baseline to first follow up showed a mean  
increase in 259.8±42.78 and P < 0.05 which is s tatistically  
significant. The patient’s BP (Systolic) level from baseline 
to first follow up showed a mean increase in 131.6±2.05 
and P < 0.05 which is statistically significant. The patient’s 
BP (Diastolic) level from baseline to first follow up 
showed a mean increase in 85.4±0.79 and P < 0.05 which  
is statistically significant. The details of lab data Average 
baseline to Average I follow up shown in table 4. 
 
Table 4: Details of lab data Average baseline to Average I fo llow up 
Parameter Average Baseline Average I Follow up Mean ± SD P- Value 
FPG 205.8 161.2 183.5±31.54 P<0.05 
PPG 290.9 229.5 259.8±42.78 P<0.05 
BP (Systolic) 133.2 130.1 131.6±2.05 P<0.05 
BP (Diastolic) 86.07 84.88 85.4±0.79 P<0.05 
  
Hinchageri et al                                   Journal of Drug Delivery & Therapeutics; 2012, 2(4), 147-151    150 
© 2011, JDDT. All Rights Reserved                                                          ISSN: 2250-1177                                                   CODEN (USA): JDDTAO 
 
Figure 1: Details of lab data Average baseline to Average I follow up  
Assessment of patient’s FPG level from baseline to second 
follow up showed a mean increase in 160.3±64.42 and P < 
0.05 which is statistically significant.  The patient’s PPG 
level from baseline to second follow up showed a mean 
increase in 242.6±68.31 and P < 0.05 which is statistically  
significant.  The patient’s HbA1c level from baseline to 
second follow up showed a mean increase in 9.57±0.78 
and P < 0.05 which is statistically significant. The patient’s 
BP (Systolic) level from baseline to second follow up 
showed a mean increase in 130.7±3.53 and P < 0.05 which  
is statistically significant. The patient’s BP (Diastolic) 
level from baseline to second follow up showed a mean 
increase in 84.9±1.16 and P < 0.05 which is statistically  
significant.  The Details of lab data Average baseline to 
Average II fo llow up shown in table 5.  
Table 5: Details of lab data Average baseline to Average II follow up  
Parameter Average Baseline Average II Follow up Mean ± SD P- Value 
FPG 205.8 114.7 160.3±64.42 P<0.05 
PPG 290.9 194.3 242.6±68.31 P<0.05 
HbA1c 10.13 9.02 9.57±0.78 P<0.05 
BP (Systolic) 133.2 128.2 130.7±3.53 P<0.05 
BP (Diastolic) 86.07 83.79 84.9±1.16 P<0.05 
  
 
Figure 2: Details of lab data Average baseline to Average II follow up 
DISCUSS ION:  
The management of Diabetes Mellitus not only requires 
the prescription of the appropriate nutritional and 
pharmacological regimen by the physician but also 
intensive patient education and counseling. Diabetes is a 
chronic disease with altered carbohydrate, lipid and protein  
metabolism. The chronic diabetic complications are known 
to affect the quality of life of patients. Various factors like  
understanding of the patients about their disease, 
socioeconomic factors, dietary regulation, self monitoring 
of blood glucose are known to play a vital role in diabetes 
management.
7,15 
In the present study shows that, number of male patients 
visiting to Inpatient department found to be more than the 
female might be due to uncontrolled diet and lack of 
lifestyle modification. The study observed that, more than 
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50% of patients having a cardiovascular complicat ion  
mainly hypertension and ischemic diseases , may be due to 
lack o f knowledge over diabetic complication, 
uncontrolled diet and lack of lifestyle modificat ion. The 
prescription detail of the patients shows that, 37.2% of the 
patient s on combination of Insulin and OAD’s. Here the 
blood glucose not controlled only with OAD’s, so the 
patients have been added with insulin therapy along with 
OAD’s.  The baseline knowledge of the patient towards 
diet, disease and medication adherence was found to be 
very low because most of the patient visiting to the 
Basaveshwar teaching and general hospital is from rural 
area where more illiterateracy and lack of patient 
educators. The lab parameters were observed at baseline 
and further for two fallow ups , that shows statistically  
significant improvement from baseline to first and second 
follow up. The positive improvement in lab parameter 
(clinical outcome) due to improvement in patient’s  
knowledge, d ietary modification, lifestyle changes, 
understanding of disease, medication and improved 
medication adherence after providing patient education.  
The study further suggest,  patient education by care 
providers such as physicians, pharmacist and nursing staff 
is essential to encourage the patients for regular physical 
activity, improve dietary habits,  lifestyle modification, 
understanding of disease, to increase medication 
knowledge and adherence, which helps for improving 
clin ical outcome in diabetic patients as well as other 
chronic diseases .  
CONCLUS ION: 
The management of diabetes requires the combination of 
pharmacological and nonpharmacological measures. The 
patient education over dietary changes, lifestyle 
modification, patients understanding over disease, diabetic 
complications, knowledge of medicat ion and medicat ion 
adherence help to improve clinical outcome, reduce 
diabetic complications and which leads to improve 
patient’s quality of life. The overall study concludes that, 
the proper patient education is essential is to improve 
clin ical outcome diabetic patients.   
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